Recent Advances in the Diagnosis of Talaromycosis

Talaromycosis is an invasive fungal disease endemic to Southeast Asia. While culture is essential in identification, susceptibility testing, and typing, the low sensitivity and long turnaround times limit its clinical utility. Several promising monoclonal antibody-based (MAb) antigen-detection assays have been evaluated in large patient cohorts. This includes the MAb-Mp1p and MAb-4D1 enzyme immunoassays and their point-of-care platforms. Quantitative polymerase chain reaction (qPCR) assays targeting the 5.8S or 18S region of ribosomal RNA have been developed. These antigen and qPCR assays are highly specific and more sensitive than blood culture, making them excellent rapid rule-in tests for talaromycosis in people with a compatible clinical syndrome. Metagenomic next-generation sequencing is emerging as a promising tool for non-bias detection of talaromycosis. Host-based diagnostics targeting antibodies, interferon-gamma release, and transcriptomics are being actively developed. This review summarizes recent advances in the diagnosis of talaromycosis and provides expert recommendations on the application of these novel tests to improve the diagnostic algorithm and management of talaromycosis.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-05-15
DOI
https://doi.org/10.1093/cid/ciaf253
Citations
6
Primary Topic
Fungal Infections and Studies
Type
article
Field-Weighted Citation Impact
8.13

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent Advances in the Diagnosis of Talaromycosis

Linghua Li, Tihana A. Bicanic, Lottie Brown, Methee Chayakulkeeree et al.
6 citations
Clinical Infectious Diseases
Fungal Infections and Studies
8.13
article

Recent Advances in the Diagnosis of Talaromycosis

Linghua Li, Tihana A. Bicanic, Lottie Brown, Methee Chayakulkeeree, Thuy Le, Jasper Fuk‐Woo Chan, Ngô Thị Hoa, Sirida Youngchim, Vo Trieu Ly, Kwok‐Yung Yuen, Cunwei Cao
article en
6 citations

Abstract

Talaromycosis is an invasive fungal disease endemic to Southeast Asia. While culture is essential in identification, susceptibility testing, and typing, the low sensitivity and long turnaround times limit its clinical utility. Several promising monoclonal antibody-based (MAb) antigen-detection assays have been evaluated in large patient cohorts. This includes the MAb-Mp1p and MAb-4D1 enzyme immunoassays and their point-of-care platforms. Quantitative polymerase chain reaction (qPCR) assays targeting the 5.8S or 18S region of ribosomal RNA have been developed. These antigen and qPCR assays are highly specific and more sensitive than blood culture, making them excellent rapid rule-in tests for talaromycosis in people with a compatible clinical syndrome. Metagenomic next-generation sequencing is emerging as a promising tool for non-bias detection of talaromycosis. Host-based diagnostics targeting antibodies, interferon-gamma release, and transcriptomics are being actively developed. This review summarizes recent advances in the diagnosis of talaromycosis and provides expert recommendations on the application of these novel tests to improve the diagnostic algorithm and management of talaromycosis.

Clinical Infectious DiseasesVol. 81(6)
Siriraj Hospital (TH), Guangxi Medical University (CN), St George's, University of London (GB), Duke University (US), Pham Ngoc Thach University of Medicine (VN), Mahidol University (TH), Angkor Hospital for Children (KH), St George’s University Hospitals NHS Foundation Trust (GB), University of Oxford (GB), First Affiliated Hospital of GuangXi Medical University (CN), Oxford University Clinical Research Unit (VN), Hospital for Tropical Diseases (VN), Guangzhou Eighth People's Hospital (CN), Institute of Infection and Immunity (CA), City St George's, University of London (GB), Chiang Mai University (TH), University of Hong Kong (HK), Guangzhou Medical University (CN)
National Institute for Health and Care Research, Federation of European Microbiological Societies, Harold Hyam Wingate Foundation, Dowager Countess Eleanor Peel Trust, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 2%
Fungal Infections and Studies
8.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.